Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:11:59.488Z.
Calculation as of: 2026-10-06T15:11:59.488Z.
Quote observation: 2026-10-06T15:10:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a99f3f088f54f9f9c0225e5104dac3e52b54f392bb47ad8d1f9af79329b73e7d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$4.42B
EV/FCF Ratio
N/A
TTM Avg
30.27x
3Y Avg
50.30x
5Y Avg
44.46x
Market Cap
$4.45B
EV/FCF Ratio
N/A
TTM Avg
17.76x
3Y Avg
17.76x
5Y Avg
17.76x
Market Cap
$4.08B
EV/FCF Ratio
N/A
TTM Avg
17.56x
3Y Avg
217.22x
5Y Avg
217.22x
Market Cap
$4.62B
EV/FCF Ratio
127.21x
TTM Avg
178.16x
3Y Avg
178.16x
5Y Avg
178.16x
Market Cap
$4.64B
EV/FCF Ratio
N/A
TTM Avg
20.21x
3Y Avg
23.58x
5Y Avg
29.57x
Market Cap
$4.66B
EV/FCF Ratio
26.65x
TTM Avg
24.76x
3Y Avg
35.67x
5Y Avg
35.67x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.36B | N/A | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.42B | N/A | 30.27x | 50.30x | 44.46x |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | N/A | 17.76x | 17.76x | 17.76x |
| LivaNova PLC (LIVN)vs › | $4.12B | 26.67x | 21.61x | 72.06x | 67.94x |
| AbCellera Biologics Inc. (ABCL)vs › | $4.08B | N/A | 17.56x | 217.22x | 217.22x |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 127.21x | 178.16x | 178.16x | 178.16x |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | N/A | 20.21x | 23.58x | 29.57x |
| LifeStance Health Group, Inc. (LFST)vs › | $4.66B | 26.65x | 24.76x | 35.67x | 35.67x |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
